# QTc Information in Human Prescription Drug and Biological Product Labeling: Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/qtc-information-in-human-prescription-drug-and-biological-product-labeling-draft-guidance-for-industry/31125149-7d83-4062-9793-55cba93d1ee0

> FDA guidance document: QTc Information in Human Prescription Drug and Biological Product Labeling: Draft Guidance for Industry. Issue date: August 08, 2023. Get complete insights and analysis.

---

## Details

- Title: QTc Information in Human Prescription Drug and Biological Product Labeling: Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2023-08-08
- Comment Close Date: 2023-10-10
- Last Changed: 2023-08-08
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2023-D-2439">FDA-2023-D-2439</a>

## Related Documents

- [Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-bayesian-methodology-in-clinical-trials-of-drug-and-biological-products-draft-guidance-for-industry/8e9c345e-0994-47b3-8d6c-054f04ed937e)
- [Drug Master Files Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-master-files-guidance-for-industry/7dfd5140-3156-43f2-bdb9-d23ad597311c)
- [Tissue Agnostic Drug Development in Oncology: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/tissue-agnostic-drug-development-in-oncology-draft-guidance-for-industry/3835823e-c995-46e5-98c7-9422ad94971f)